Skip to main content
PMC home page
Journal of Virology logoLink to Journal of Virology
. 1985 Apr;54(1):53–57. doi: 10.1128/jvi.54.1.53-57.1985

Cytotoxic T-lymphocyte reactivity with individual Sendai virus glycoproteins.

M N Al-Ahdal, I Nakamura, T D Flanagan
PMCID: PMC254759  PMID: 2983119

Abstract

Liposomes were constituted with affinity-purified Sendai virus glycoproteins HN and F and phosphatidylcholine (PC) or phosphatidylethanolamine: phosphatidylserine (PEPS). The glycoprotein-bearing recombinant vesicles (RV) were used to modify the surface of P815 mastocytoma cells (H-2d) or EL4 lymphoma cells (H-2b). The cells treated with HN-F-PCRV, HN-PEPSRV, or F-PEPSRV were shown by surface immunofluorescence to retain antigen for at least 2 h at 37 degrees C after treatment. The modified cells were used in cytotoxicity assays with effector spleen cells from either DBA/2 (H-2d) or C57BL/6 (H-2b) immunized by inoculation of active Sendai virus. Cells modified by treatment with HN/F-PCRV showed susceptibility to cytolysis similar to that in actively infected cells. Cells modified with HN-PEPSRV or with F-PEPSRV were also susceptible. The sum of reactivities of the anti-HN component and the anti-F components was close to that seen with HN- and F-bearing targets. Syngeneic but not allogeneic target cells expressing Sendai virus glycoproteins were bound and lysed by the effector cells, which was expected if the interactions were major histocompatibility complex restricted. The activity was attributed to cytotoxic T lymphocytes, since it was depleted by treatment with anti-Thy 1.2 antibody and complement.

Full text

PDF
53

Images in this article

55Image
on p.55

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abidi T. F., Flanagan T. D. Cell-mediated cytotoxicity against targets bearing Sendai virus glycoproteins in the absence of viral infection. J Virol. 1984 May;50(2):380–386. doi: 10.1128/jvi.50.2.380-386.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976 May 7;72:248–254. doi: 10.1016/0003-2697(76)90527-3. [DOI] [PubMed] [Google Scholar]
  3. Choppin P. W., Scheid A. The role of viral glycoproteins in adsorption, penetration, and pathogenicity of viruses. Rev Infect Dis. 1980 Jan-Feb;2(1):40–61. doi: 10.1093/clinids/2.1.40. [DOI] [PubMed] [Google Scholar]
  4. Doherty P. C., Zinkernagel R. M. Specific immune lysis of paramyxovirus-infected cells by H-2-compatible thymus-derived lymphocytes. Immunology. 1976 Jul;31(1):27–32. [PMC free article] [PubMed] [Google Scholar]
  5. Finberg R., Mescher M., Burakoff S. J. The induction of virus-specific cytotoxic T lymphocytes with solubilized viral and membrane proteins. J Exp Med. 1978 Dec 1;148(6):1620–1627. doi: 10.1084/jem.148.6.1620. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Hale A. H., Lyles D. S., Fan D. P. Elicitation of anti-Sendai virus cytotoxic T lymphocytes by viral and H-2 antigens incorporated into the same lipid bilayer by membrane fusion and by reconstitution into liposomes. J Immunol. 1980 Feb;124(2):724–731. [PubMed] [Google Scholar]
  7. Hale A. H., Ruebush M. J., Lyles D. S., Harris D. T. Antigen-liposome modification of target cells as a method to alter their susceptibility to lysis by cytotoxic T lymphocytes. Proc Natl Acad Sci U S A. 1980 Oct;77(10):6105–6108. doi: 10.1073/pnas.77.10.6105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Haywood A. M. Characteristics of Sendai virus receptors in a model membrane. J Mol Biol. 1974 Mar 15;83(4):427–436. doi: 10.1016/0022-2836(74)90504-x. [DOI] [PubMed] [Google Scholar]
  9. Kibler R., Solvay M. J., ter Meulen V. Cell-mediated cytotoxicity: comparison of primary and secondary immune reactions after parainfluenza type 1 virus inoculation. Exp Cell Biol. 1978;46(1-2):11–30. doi: 10.1159/000162880. [DOI] [PubMed] [Google Scholar]
  10. Koszinowski U., Gething M. J., Waterfield M. T-cell cytotoxicity in the absence of viral protein synthesis in target cells. Nature. 1977 May 12;267(5607):160–163. doi: 10.1038/267160a0. [DOI] [PubMed] [Google Scholar]
  11. Ledbetter J. A., Herzenberg L. A. Xenogeneic monoclonal antibodies to mouse lymphoid differentiation antigens. Immunol Rev. 1979;47:63–90. doi: 10.1111/j.1600-065x.1979.tb00289.x. [DOI] [PubMed] [Google Scholar]
  12. McGee M., Hale A. H., Panetti M. Elicitation of primary anti-Sendai virus cytotoxic T lymphocytes with purified viral glycoproteins. Eur J Immunol. 1980 Dec;10(12):923–928. doi: 10.1002/eji.1830101207. [DOI] [PubMed] [Google Scholar]
  13. Nakamura I., Cudkowicz G. Requirement of parental T lymphocytes for the in vitro induction of F1 hybrid anti-parent cytotoxicity. Eur J Immunol. 1979 May;9(5):371–379. doi: 10.1002/eji.1830090507. [DOI] [PubMed] [Google Scholar]
  14. Sugamura K., Shimizu K., Zarling D. A., Bach F. H. Role of sendai virus fusion-glycoprotein in target cell susceptibility to cytotoxic T cells. Nature. 1977 Nov 17;270(5634):251–253. doi: 10.1038/270251a0. [DOI] [PubMed] [Google Scholar]
  15. Urata D. M., Seto J. T. Glycoproteins of Sendai virus: purification and antigenic analysis. Intervirology. 1975;6(2):108–114. doi: 10.1159/000149462. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES